Breaking News, Promotions & Moves

Emergent Names Management for Spin-off

Bioscience company Aptevo Therapeutics to be operational mid-2016

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Emergent BioSolutions has announced the executive management team of Aptevo Therapeutics, Emergent’s planned biosciences business spin-off company. Members of the Aptevo executive management team will be appointed to their positions effective upon completion of the tax-free spin-off of Aptevo, expected to occur in mid-2016. “We are pleased to have such an experienced and talented group of individuals to lead Aptevo Therapeutics,” said Daniel Abdun-Nabi, president and chief executive officer, ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters